• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心力衰竭中利尿剂使用、临床反应与死亡之间的关联

Association between diuretic use, clinical response, and death in acute heart failure.

作者信息

Philbin E F, Cotto M, Rocco T A, Jenkins P L

机构信息

Cardiac Unit, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.

出版信息

Am J Cardiol. 1997 Aug 15;80(4):519-22. doi: 10.1016/s0002-9149(97)00409-8.

DOI:10.1016/s0002-9149(97)00409-8
PMID:9285672
Abstract

Because the impact of diuretic use on mortality in acute congestive heart failure (CHF) is not known, we examined the association between drug use, fluid balance, and death among 1,150 patients hospitalized for evaluation and treatment of CHF. After adjusting for other relevant intergroup differences, we observed that less net weight loss and a greater number of intravenous drug doses retained significant predictive value for death, suggesting that more frequent diuretic dosing or diuretic resistance may be related to mortality in acute CHF.

摘要

由于利尿剂使用对急性充血性心力衰竭(CHF)死亡率的影响尚不清楚,我们研究了1150名因CHF评估和治疗而住院的患者的药物使用、液体平衡与死亡之间的关联。在对其他相关组间差异进行调整后,我们观察到较少的净体重减轻和较多的静脉用药剂量对死亡具有显著的预测价值,这表明更频繁的利尿剂给药或利尿剂抵抗可能与急性CHF的死亡率有关。

相似文献

1
Association between diuretic use, clinical response, and death in acute heart failure.急性心力衰竭中利尿剂使用、临床反应与死亡之间的关联
Am J Cardiol. 1997 Aug 15;80(4):519-22. doi: 10.1016/s0002-9149(97)00409-8.
2
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.在伴有明显液体潴留的慢性心力衰竭中,静脉注射大剂量袢利尿剂是肾功能恶化的一个预测指标,尤其是在左心室收缩功能正常或仅轻度受损的心力衰竭患者中。
Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18.
3
The problem of ventricular dysrhythmias and sudden death mortality in heart failure: the impact of current therapy.心力衰竭中室性心律失常和猝死死亡率的问题:当前治疗的影响。
Cardiology. 2000;93(1-2):56-69. doi: 10.1159/000007003.
4
Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment.急性失代偿性心力衰竭治疗期间液体与体重减轻之间的显著差异。
Am J Med. 2015 Jul;128(7):776-83.e4. doi: 10.1016/j.amjmed.2014.12.020. Epub 2015 Jan 13.
5
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).急性心力衰竭住院期间及出院后充血症状的缓解与复发:急性失代偿性心力衰竭利尿优化策略评估(DOSE-AHF)及急性失代偿性心力衰竭心肾挽救研究(CARESS-HF)的见解
Circ Heart Fail. 2015 Jul;8(4):741-8. doi: 10.1161/CIRCHEARTFAILURE.114.001957. Epub 2015 Jun 3.
6
Diuretic resistance predicts mortality in patients with advanced heart failure.利尿剂抵抗可预测晚期心力衰竭患者的死亡率。
Am Heart J. 2002 Jul;144(1):31-8. doi: 10.1067/mhj.2002.123144.
7
[Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].[根据药物治疗及其效果对心力衰竭患者进行心律失常风险分层]
Ital Heart J Suppl. 2001 Dec;2(12):1278-83.
8
Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure.急性心力衰竭患者的低氯血症、利尿剂抵抗与预后
Circ Heart Fail. 2016 Aug;9(8). doi: 10.1161/CIRCHEARTFAILURE.116.003109.
9
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.美托洛尔与卡维地洛对慢性心力衰竭患者特定病因死亡率和发病率的影响——COMET研究
Am Heart J. 2005 Feb;149(2):370-6. doi: 10.1016/j.ahj.2004.10.002.
10
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.结合利尿反应和血液浓缩预测急性心力衰竭入院后的再住院情况。
Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.002845.

引用本文的文献

1
Furosemide-hydration matching with RenalGuard in decompensated heart failure: an alternative way to use diuretics and saline.在失代偿性心力衰竭中速尿与RenalGuard水合作用的匹配:利尿剂和生理盐水的一种使用方式
ESC Heart Fail. 2025 Aug;12(4):3200-3208. doi: 10.1002/ehf2.15316. Epub 2025 Apr 28.
2
Association between loop diuretic dose administered in first 24 hours of heart failure admissions and length of hospital stay.心力衰竭入院后首个24小时使用的袢利尿剂剂量与住院时间之间的关联。
J Community Hosp Intern Med Perspect. 2018 Aug 23;8(4):195-199. doi: 10.1080/20009666.2018.1503916. eCollection 2018.
3
Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide.
沙库巴曲缬沙坦对单次呋塞米药代动力学和药效学的影响。
Br J Clin Pharmacol. 2018 May;84(5):926-936. doi: 10.1111/bcp.13505. Epub 2018 Feb 20.
4
Impact of Cardiorenal Anemia Syndrome on Short- and Long-Term Clinical Outcomes in Patients Hospitalized with Heart Failure.心肾贫血综合征对心力衰竭住院患者短期和长期临床结局的影响。
Cardiorenal Med. 2016 Aug;6(4):269-78. doi: 10.1159/000443339. Epub 2016 Apr 28.
5
Diuretic dosing in acute decompensated heart failure: lessons from DOSE.急性失代偿性心力衰竭的利尿剂给药:DOSE研究的经验教训
Curr Heart Fail Rep. 2012 Sep;9(3):260-5. doi: 10.1007/s11897-012-0094-8.
6
Pathogenesis and therapeutic implications of cardiorenal syndrome.心肾综合征的发病机制及治疗意义。
Clin Exp Nephrol. 2011 Apr;15(2):187-94. doi: 10.1007/s10157-010-0374-0. Epub 2010 Nov 23.
7
Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.心力衰竭中的袢利尿剂治疗:对液体问题的确实证据的需求。
Clin Cardiol. 2010 Jun;33(6):345-52. doi: 10.1002/clc.20771.
8
Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?急性失代偿性心力衰竭中使用袢利尿剂:必要吗?有害吗?一种必要的有害物?
Circ Heart Fail. 2009 Jan;2(1):56-62. doi: 10.1161/CIRCHEARTFAILURE.108.821785.
9
Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure.急性心肾综合征:从充血性心力衰竭进展至充血性肾衰竭。
Curr Heart Fail Rep. 2007 Sep;4(3):134-8. doi: 10.1007/s11897-007-0031-4.
10
The role of ultrafiltration in the management of heart failure.超滤在心力衰竭管理中的作用。
Curr Treat Options Cardiovasc Med. 2006 Aug;8(4):301-9. doi: 10.1007/s11936-006-0051-5.